Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Theratechnologies Has Received FDA Correspondence Regarding Its Supplemental Biologics License Application For F8 Formulation Of Tesamorelin, Notifying To Continue The Review Of The Application Beyond The PDUFA Date Of January 22

Author: Benzinga Newsdesk | January 23, 2024 08:38am

Posted In: THTX